Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention
- PMID: 17227807
- PMCID: PMC2675425
- DOI: 10.1136/adc.2005.088799
Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention
Abstract
Objectives: (1) To describe the epidemiology of neonatal group B streptococcal (GBS) disease over five years (1997-2001) in the Netherlands, stratified for proven and probable sepsis and for very early (<12 h), late early (12 h - <7 days) and late (7-90 days) onset sepsis. (2) To evaluate the effect of the introduction in January 1999 of guidelines for prevention of early onset GBS disease based on risk factors.
Methods: Data on cases were collected in collaboration with the Dutch Paediatric Surveillance Unit and corrected for under-reporting by the capture-recapture technique.
Results: Total incidence of proven very early onset, late early onset and late onset GBS sepsis was 0.32, 0.11 and 0.14 per 1000 live births, respectively, and of probable very early onset, late early onset and late onset GBS sepsis was 1.10, 0.18 and 0.02 per 1000 live births, respectively. Maternal risk factors were absent in 46% of the proven early onset cases. Considerably more infants with proven GBS sepsis were boys. 64% of the infants with proven very early onset GBS sepsis were first born compared with 47% in the general population. After the introduction of guidelines the incidence of proven early onset sepsis decreased considerably from 0.54 per 1000 live births in 1997-8 to 0.36 per 1000 live births in 1999-2001. However, there was no decrease in the incidence of meningitis and the case fatality rate in the first week of life. The incidence of late onset sepsis also remained unchanged.
Conclusion: After the introduction prevention guidelines based on risk factors there has been a limited decrease in the incidence of proven early onset GBS sepsis in the Netherlands. This study therefore recommends changing the Dutch GBS prevention guidelines.
Conflict of interest statement
Competing interests: None.
Comment in
-
Group B streptococcus and preventive strategies in Europe.Arch Dis Child Fetal Neonatal Ed. 2008 May;93(3):F249. doi: 10.1136/adc.2007.135392. Arch Dis Child Fetal Neonatal Ed. 2008. PMID: 18426928 No abstract available.
References
-
- Boyer K M, Gotoff S P. Prevention of early‐onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 19863141665–1669. - PubMed
-
- Trijbels‐Smeulders M A J M, Kollée L A A, Adriaanse A H.et al Neonatal group B streptococcal (GBS) infection: incidence and strategies for prevention in Europe. Pediatr Infect Dis 200423172–173. - PubMed
-
- Centers for Disease Control and Prevention Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep 1996451–24. - PubMed
-
- Rouse D J, Goldenberg R L, Cliver S P. Strategies for the prevention of early‐onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 199483483–494. - PubMed
-
- Schuchat A, Wenger J D. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies and vaccine development. Epidemiol Rev 199416374–402. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical